Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Name: Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
License: Public Domain

Intergroupe Francophone de Cancerologie Thoracique

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

mesothelioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300249
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.